Trial Profile
Tirasemtiv Amplifies Skeletal Muscle Response to Nerve Activation in Humans
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Sep 2014
Price :
$35
*
At a glance
- Drugs Tirasemtiv (Primary)
- Indications Amyotrophic lateral sclerosis; Muscle fatigue; Myasthenia gravis; Spinal muscular atrophy
- Focus Pharmacodynamics
- Sponsors Cytokinetics
- 19 Sep 2014 New trial record